Q301--NGS Malignancy Testing
Closed Pre-Solicitation Posted
- Solicitation number
- 36C25026Q0709
- Agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Richard L. Roudebush Vamc 1481 W. 10th St. Indianapolis, Indiana 46202, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Veterans Integrated Service Network 10 is conducting a sources sought to identify vendors capable of providing hematologic malignancy Next Generation Sequence (NGS) and Immunohistochemistry (IHC) testing services at the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana, with responses due by July 14, 2026. This is a planning notice only and does not constitute a solicitation or obligation to award; no funds have been authorized or appropriated.
The anticipated requirement is a one-year, firm fixed price contract for the Hematology department's Pathology & Laboratory Medicine Service to provide repeat NGS testing not covered under the VA National Precision Oncology Program for patients with changes in diagnosis. NGS testing must deliver detailed gene test results covering at least 600 targeted genes using advanced gene-level test methodology on patient blood specimens and produce detailed treatment plans. The contractor must be a certified laboratory, maintain HIPAA compliance, ensure 24/7 accessibility, deliver samples to the testing facility within three days, and report results within 14 days (or longer if pre-approved). Specimens shall be retained per regulatory agency requirements (minimum 14 days if no regulatory requirement exists). The contractor must conduct minimum daily quality controls, provide written sample preparation and transportation instructions, distinguish FDA-approved tests from research-only tests on result sheets, and notify the VA within two hours of identified sample problems and at least 10 business days before any test methodology changes.
Interested vendors must submit responses via email to Contract Specialist Jessica D. Bryant (jessica.bryant5@va.gov) or Tiera T. Sims (tiera.sims@va.gov) and include company contact information, UEI and SAM.gov registration, socioeconomic status, GSA/FSS contract number if applicable, a capability statement, and up to three past performance examples. NAICS code 621511 applies.
Notice text
SOURCES SOUGHT NOTICE
This Sources Sought Notice is to determine the presence of any businesses capable of satisfying a requirement at the Richard L. Roudebush VAMC for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens.
NOTE TO RESPONDERS: This Sources Sought Notice is for planning purposes only and shall not be considered as an invitation for bid, request for quotation, request for proposal, or as an obligation on the part of the Government to acquire any products or services. Your response to this Sources Sought Notice will be treated as information only. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor submission of responses to this announcement or the Government use of such information. This request does not constitute a solicitation for proposals or the authority to enter negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort.
BACKGROUND
The Hematology department at Richard L. Roudebush VA Medical Center s Pathology & Laboratory Medicine Service (PALMS) requires a one-year, firm fixed price contract for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NGS testing is an advanced test methodology at the gene level for detecting various forms of diseases through patient blood specimens. Testing shall provide detailed gene test results of at least 600 targeted genes and produce detailed treatment plans. This contract is needed for Hematology providers to obtain repeat NGS testing that may not be covered under the VA National Precision Oncology Program (NPOP) national contract, for patients with changes in their diagnosis.
North American Industry Classification System (NAICS) code: 621511
VENDOR CAPABILITY
Interested and qualified vendors are encouraged to respond with:
Your company s point of contact s name, street address, e-mail address, telephone number, UEI & sam.gov registration, NAICS code, and Socio-economic status (Small Business, Woman Owned Small Business, Service-Disabled Veteran Owned Small Business, etc.), and GSA/FSS Contract Number (if applicable).
A capability statement that adequately describes the contractor s ability to meet the requirement.
Contractor shall provide any applicable past performance on contracts of this nature. Please provide no more than three (3) examples.
Interested parties are responsible for adequately marking proprietary information contained in their response. The Government does not intend to pay for the information submitted in response to this Sources Sought Notice. All information received in response to this notice that is marked as proprietary will be handled accordingly.
GOVERNMENT POINT OF CONTACT
No phone calls will be accepted. Responses will only be accepted via email, no later than Tuesday July 14, 2026, at 12pm EST.
Primary Point of Contact:
Jessica D. Bryant
Contract Specialist
E-mail: Jessica.Bryant5@va.gov
Secondary Point of Contact:
Tiera T. Sims
Contract Specialist
E-mail: Tiera.Sims@va.gov
Files
| File | Type | Posted |
|---|---|---|
| 36C25026Q0709.docx | DOCX document | |
| NGS Statement of Work 2026.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside | |
| B533--VANIHCS SPS Water Testing (VA-27-00000760) | Veterans Integrated Service Network 10 | Service-Disabled Veteran-Owned Small Business | |
| Emergent reference lab testing | Veterans Integrated Service Network 7 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity